Prediction of immunogenicity for humanized and full human therapeutic antibodies.
Immunogenicity is an important concern for therapeutic antibodies during drug development. By analyzing co-crystal structures of idiotypic antibodies and their antibodies, we found that anti-idiotypic antibodies usually bind the Complementarity Determining Regions (CDR) of idiotypic antibodies. Sequ...
Main Authors: | Shide Liang, Chi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0238150 |
Similar Items
-
The immunogenicity of human-origin therapeutic antibodies are associated with V gene usage
by: Zicheng Hu, et al.
Published: (2023-09-01) -
The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibody.
by: Routledge, E, et al.
Published: (1995) -
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
by: Aimee E. Mattei, et al.
Published: (2024-12-01) -
Elimination of the immunogenicity of therapeutic antibodies.
by: Gilliland, L, et al.
Published: (1999) -
Human monoclonal antibodies: the residual challenge of antibody immunogenicity.
by: Waldmann, H
Published: (2014)